Dfmo and celecoxib in combination for cancer chemoprevention and therapy
CA 2373931 A1 · Owner: Ilex Oncology, Inc. · Inventors: Love, Richard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Celecoxib, a COX-2 specific non-steroidal anti-inflammatory agent is provided , in combination with DFMO for the prevention and/or treatment of cancers. Provided with the present invention are pharmaceutically acceptable compositions that include a non-steroidal anti-inflammatory agent celecoxib, together with an effective amount of difluoromethylornithine.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 17, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 17, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 17, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.